MaxCyte, Inc. (LON:MXCT – Get Free Report)’s share price crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of GBX 1.24 and traded as low as GBX 1.22. MaxCyte shares last traded at GBX 1.22, with a volume of 393,988 shares.
MaxCyte Trading Down 2.5%
The company’s 50 day simple moving average is GBX 1.24 and its 200-day simple moving average is GBX 1.04. The firm has a market cap of £1.27 million, a P/E ratio of -0.03 and a beta of 1.13. The company has a quick ratio of 14.38, a current ratio of 12.39 and a debt-to-equity ratio of 9.70.
About MaxCyte
MaxCyte is a leading cell-engineering company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research. MaxCyte brings best-in-class technology paired with ongoing support designed to facilitate complex engineering of a wide variety of cells and payloads, with the aim of advancing new treatment options for patients. For over 20 years, MaxCyte has been perfecting the art of cell-engineering, venturing beyond today’s process to innovate tomorrow’s solutions.
Recommended Stories
- Five stocks we like better than MaxCyte
- Nasdaq’s $100 Million Kraken Bet Prepares It for a Market That Never Closes
- Copper’s Record Rally Highlights a Deeper Supply Problem
- Rocket Lab Tackles a Supply Chain Bottleneck as the Stock Hunts for a Bottom. Time to Buy?
- Optical Cable Corporation Is Starting to Get the Market’s Attention
Receive News & Ratings for MaxCyte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MaxCyte and related companies with MarketBeat.com's FREE daily email newsletter.
